Introduction
Chronic kidney disease (CKD) is a major public health problem worldwide [1] . CKD remains largely undetected due to its asymptomatic nature, and the adverse outcomes including cardiovascular morbidity, mortality and renal failure could potentially be prevented if detected early [2] . In 2002, the National Kidney Foundation's Kidney Disease Outcome Quality Initiative (KDOQI) working group developed a new definition for early detection of CKD based on glomerular filtration rate (GFR) and micro/macroalbuminuria [2] . Recent epidemiological studies conducted in Western populations have provided estimates on the prevalence of CKD [3] [4] [5] [6] , with some suggesting significant interracial/ethnic disparities in both the prevalence [7, 8] and risk factors of CKD [9, 10] . Asians have been suggested to have an increased risk for renal disease compared to whites [11] , and the contribution of some of the risk factors of CKD also appears to be different among Asian populations [12] [13] [14] compared to Western populations. While there are studies on the epidemiology of CKD in Asia [15] , studies comparing interracial/ethnic variations in the prevalence and risk factors of CKD between the major Asian groups (e.g. Chinese vs Indians) are rare. Singapore is unique because it has three major Asian ethnic groups living in a confined geographical area.
In the current study, we aim to examine the prevalence and risk factors of CKD and compare inter-ethnic differences in a population-based sample of Chinese, Malays and Indians, the three major ethnic groups in Asia that represent more than two-thirds of world's population.
Materials and methods
The data for this study are derived from the Singapore Prospective Study Program (SP2), a population-based cross-sectional study of Chinese, Malay and Indians aged 24-95 years in Singapore. Detailed population selection and methodology have been published elsewhere [16] . In short, 10 747 participants randomly selected from one of the four previous cross-sectional studies [17] [18] [19] [20] were invited to participate in the current study. Of the 7742 eligible participants, 5157 participants attended the health examination. After excluding participants with missing data on urinary albumin-to-creatinine ratio (ACR) (n = 587), serum creatinine (n = 56), serum lipids (n = 6) and key demographic variables (n = 9), 4499 provided samples for the current analysis. The study followed the Declaration of Helsinki and was approved by the local Institutional Review Board.
Measurement of outcome
The primary outcome of interest in the current study was CKD defined as (i) estimated GFR (eGFR) <60 mL/min/1.73 m 2 , an outcome related to kidney function or (ii) presence of micro/macroalbuminuria defined as urinary ACR ≥30 mg/g, an outcome related to kidney damage based on the KDOQI definition [2] . Also, based on the presence of micro/ macroalbuminuria and the level of eGFR, CKD was classified into five stages: [2] Earlier stages (stages 1 and 2) were defined based on the combination of micro/macroalbuminuria and eGFR, whereas moderate (stage 3) and severe (stages 4 and 5) stages were defined solely based on the level of eGFR.
GFR was estimated from serum creatinine concentration using the Modification of Diet in Renal Disease (MDRD) equation [21] defined as follows: eGFR = 186.3 × (serum creatinine in mg/dL) −1.154 × age −0.203 × (0.742 for women). Serum creatinine measurement was carried out at the National University Hospital Reference Laboratory and was reported in micromoles per litre. Plasma creatinine was measured by enzymatic methods (ADVIA 2400, Bayer Diagnostics). The creatinine method is calibrated to the National Institute of Standards and Technology (NIST) Liquid Chromatography Isotope Dilution Mass Spectrometry (LC-IDMS) method recommended by the National Kidney Disease Education Program and traceable to NIST SRM967. The intra-and inter-assay coefficients of variation for this assay were 2.50-6.60% and 5.60-7.20%, respectively. Spot untimed urine samples were collected for measurement of albumin and creatinine. Albumin was measured in milligrams per litre and creatinine in millimoles per litre. ACR concentration expressed in micrograms per milligram was used to estimate total daily albumin excretion. Random urinary spot albumin and creatinine were measured using commercial assays (Immulite, DPC, UK and Roche Diagnostics GmbH, Mannheim for urinary albumin and creatinine, respectively). The lower detection limits for urinary albumin and creatinine were 0.5 mg/L and 0.027 mmol/L, respectively.
Measurement of risk factors
An interviewer-administered questionnaire was used to collect information on sociodemographic and lifestyle factors. Physical examination included anthropometric measurements, blood pressure (BP) and detailed ocular examination including retinal photography. Laboratory examination included measurement of plasma glucose, lipids, serum creatinine and C-reactive protein (CRP). Education was categorized into (i) primary or lower (≤6 years), (ii) secondary (7 to 10 years) and (iii) post-secondary (≥11 years, including university education). Cigarette smoking was categorized into current smokers, former smokers or nonsmokers and alcohol consumption into drinkers (irrespective of quantity) and nondrinkers. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in metres (kg/m 2 ). Overweight/obesity was defined as a BMI ≥25 kg/m 2 . Cardiovascular disease (CVD) was defined as selfreported myocardial infarction, angina or stroke. The average of the two systolic and diastolic BP measurements was used as the systolic and diastolic BP value. Mean arterial BP was calculated as two-thirds of the diastolic plus one-third of the systolic value. Hypertension was defined as systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg or self-reported physician-diagnosed hypertension. Diabetes mellitus was defined as fasting plasma glucose ≥7 mmol/L (≥ 126 mg/dL) or self-reported physician-diagnosed diabetes or use of glucose-lowering medication. Dyslipidaemia was defined as total cholesterol ≥6.2 mmol/L or more, low-density lipoprotein (LDL) cholesterol ≥4.1 mmol/L or more, high-density lipoprotein (HDL) cholesterol <1.0 mmol/L or self-reported physician-diagnosed dyslipidaemia. Serum lipids, plasma glucose and CRP were measured from fasting blood samples. All serum biochemistry tests were carried out at the National University Hospital Reference Laboratory.
Statistical analysis
All statistical analyses were performed using SAS version 9.1. Characteristics of the study population were examined using proportions or means and standard deviation (SD). All analyses were performed incorporating the sampling weights to adjust for unequal probability sampling from the three ethnic groups. Age-and sex-standardized prevalence estimates were calculated by the direct method using the year 2000 Singapore adult population as the standard population. The prevalence of indicators of CKD (eGFR<60 mL/min/1.73 m 2 and micro/macroalbuminuria) was estimated and compared among ethnic groups. The association of CKD with various factors among the ethnic groups was examined using logistic regression models adjusted for age and sex. To evaluate the extent that clinical and metabolic (diabetes, hypertension, systolic BP, CRP, CVD), socioeconomic (education) and behavioral (smoking, alcohol consumption, BMI, lipids) risk factors may explain the excess risk of CKD in Malays and Indians compared to Chinese, the percent reduction in odds associated with adjustment for these factors was estimated according to the following formula: (r a − r b )/(r a − 1) × 100, where r a is the odds ratio (OR) of CKD in Malays and Indians compared to Chinese adjusted for age and sex only (model 1), and r b was the OR after further adjustment in model 2 (clinical and metabolic risk factors ), model 3 (socio-economic and be- Weighted prevalence. d CKD stages 1-2 were defined based on the level of kidney function and the presence of micro/macroalbuminuria (albumin-to-creatinine ratio >17 mg/ g for men and >25 mg/g for women); stages 3-5 were defined solely based on kidney function.
havioral risk factors) and model 4 (all risk factors combined). Finally, we calculated the population-attributable risk (PAR) of CKD using Levin's formula: [22] Pd RR−1=RR ð Þ
where Pd is the proportion of cases exposed to risk factor, and RR is the adjusted relative risk estimated using the observed odds ratio [23] .
Results Table 1 shows characteristics of the study population by ethnicity. Among the three ethnic groups, Malays were more likely to be primary/below educated, smokers, had higher levels of systolic BP, diastolic BP, BMI and total and LDL cholesterol and less likely to consume alcohol; Indians were more likely to be older, had higher prevalence of diabetes, dyslipidaemia and CVD, had higher levels of CRP and lower levels of HDL cholesterol and eGFR. The crude and age-and sex-standardized prevalence of CKD estimated using MDRD equation was 15.6% and 12.8% in the whole population, 13.8% and 11.4% in Chinese, 22.8% and 18.6% in Malays and 21.9% and 17.6% in Indians. Table 2 shows the prevalence of indicators of CKD, GFR estimated by MDRD and micro/macroalbuminuria. As earlier stages of CKD are classified based on a combination of eGFR and micro/macroalbuminuria, prevalence of micro/macroalbuminuria are categorized within each level of eGFR. Majority of the participants (54.8%) had eGFR level 60-89 mL/min/1.73 m 2 . The prevalence of stages 3-5 CKD (eGFR<60 mL/min/1.73 m 2 ) was 5.5%. The prevalence of stages 1-2 CKD (micro/macroalbuminuria with eGFR ≥90 mL/min/1.73 m 2 = 11% and micro/macroalbuminuria with eGFR 60-89 mL/min/1.73 m 2 = 10.5%) was 10%. The prevalence of micro/macroalbuminuria increased with decreasing levels of kidney function with more than 70% of participants in stages 4-5 having micro/macroalbuminuria. The prevalence of CKD and both indicators of CKD were lowest among Chinese compared to other ethnic groups ( Figure 1) . Malays had the highest prevalence of micro/macroalbuminuria, and Indians had the highest prevalence of eGFR<60 mL/min/1.73 m 2 . The prevalence of CKD increased with increasing age in both male and female populations (Figure 2) . Table 3 presents the odds ratios of CKD in relation to demographic, metabolic and socioeconomic factors in the whole population and stratified by ethnic groups. In the whole population, older age, Malay and Indian ethnicity, diabetes, hypertension, dyslipidaemia, overweight/obesity, CVD, primary/below education, systolic and diastolic BP, BMI and CRP were significantly associated with CKD. Alcohol consumption and HDL cholesterol were inversely associated with CKD. Current smoking and sex were not associated with CKD. When stratified by ethnicity, older age, diabetes, hypertension, systolic and diastolic BP and dyslipidaemia were significantly associated with CKD in all ethnic groups. Table 4 shows increased age, sex-adjusted odds of CKD in Malays and Indians compared with Chinese populations. This association attenuated after adjustment for clinical and metabolic factors and socioeconomic and behavioral factors. The reduction in the odds of CKD associated with ethnicity, with adjustment for specific risk factors (model 1 to model 4), was also evaluated. The OR of CKD associated with Malay and Indian ethnicity was reduced by 50% and 63% after adjusting for clinical and metabolic risk factors and 53% and 62% after adjusting for socioeconomic and behavioral factors; adjustment for all factors reduced the excess prevalence by 68% and 78%. Figure 3 shows the PAR of the major risk factors of CKD (diabetes, hypertension and dyslipidaemia) among the three ethnic groups. The PAR of diabetes and dyslipidaemia was highest among Malays (45% and 16%) vs Chinese (25% and 4%) and Indians (22% and 7%). The PAR of hypertension was highest among Indians (23%) compared to Chinese (17%) and Malays (20%).
Discussion
The results of this population-based study involving a multi-ethnic Asian population show that the age-and sex-standardized prevalence of CKD was 12.8% in the whole population, 11.4% in Chinese, 18.6% in Malays and 17.6% in Indians. The prevalence of CKD and its indicators (eGFR<60 mL/min/1.73 m 2 and micro/macroalbuminuria) were lower in Chinese compared to Malays and Indians. Older age, diabetes, hypertension and dyslipidaemia were significantly associated with CKD in all three ethnic groups. Clinical, metabolic, socioeconomic and behavioral factors accounted for 68% of the excess risk of CKD in Malays and 78% of excess risk in Indians. The PAR of diabetes and dyslipidaemia was highest among Malays, and PAR of hypertension was highest among Indians. The crude prevalence of CKD reported in the current study (15.6%) is higher compared to Western and Asian populations. The prevalence of CKD as defined by KDO-QI is estimated to be 13.1% in the USA [4] among adults aged ≥20 years, 10.2% in Europe [5] among adults aged ≥20 years and 13.7% among volunteers aged ≥20 years in Korea. [24] The higher prevalence of CKD observed in the current study is contributed by the higher prevalence (10%) of stages 1-2 CKD. The prevalence of stages 1-2 CKD is reported to be 5.0% in the USA [4] and 5.9% in Europe [5] . The prevalence of stages 3-5 CKD (eGFR<60 mL/min/1.73 m 2 ) reported in the current study (5.5%) is similar or lower to that reported from other populations. The prevalence of stages 3-5 CKD is reported to [25] . The US [4] and Europe [5] studies used persistent albuminuria based on repeated urinary measurements. The use of single measurement of urinary ACR to define albuminuria in our study could have overestimated the prevalence of micro/macroalbuminuria resulting in increased prevalence of CKD. In the current study, CVD risk factors such as older age, diabetes, hypertension, dyslipidaemia, overweight/obesity, CVD, primary/below education, alcohol consumption and CRP were significantly associated with CKD in the whole population. Prospective studies have identified CVD risk factors such as diabetes [26, 27] , dyslipidaemia [27, 28] , high BP [29, 30] , obesity [27, 28] and smoking [27, 28, 31] as risk factors for the development of CKD. Recent crosssectional studies have documented an association between CRP and CKD [32, 33] . Contrary to previous studies, smoking was not associated with CKD in the current study. It is possible that those with CKD may have changed their lifestyle after being diagnosed with CKD risk factors such as diabetes or hypertension; furthermore, our assessment of smoking was not comprehensive, resulting in nondifferential misclassification biasing the association towards null. In the current study, alcohol consumption was found to be protective against CKD. Schaeffner et al. showed that alcohol consumption was not associated with CKD in a large cohort of male physicians in the USA [34] . However, moderate alcohol consumption was protective against CKD [34] , and heavy drinking increased the risk of CKD [35] . Again, we do not have information on the amount and frequency of drinking to test the effect of moderate or excessive drinking.
We also noted that the prevalence of CKD was higher among Malays (22.8%) and Indians (21.9%) compared to Chinese (13.8%). This is consistent with existing data. Ramirez et al. reported that Malay ethnicity is significantly associated with proteinuria compared to Chinese and Indians [14] . Migrant studies in the UK and Europe reported that Asian Indians had higher risk of CKD possibly due to ethnic susceptibility to insulin resistance, increased prevalence of diabetes and faster progression of diabetic nephropathy [36, 37] . The prevalence of major risk factors of CKD such as diabetes, hypertension, overweight/obesity and dyslipidaemia were significantly higher in Malays and Indians compared to Chinese. The PAR of diabetes (45%) and dyslipidaemia (16%) was higher among Malays, and hypertension was higher among Indians (23%). The reduction in risk of CKD associated with Malays and Indian ethnicity after adjustment for clinical, metabolic, socioeconomic and behavioral factors show that these factors largely contribute to the excess risk in Malays and Indians. The remaining excess risk for CKD in Malays and Indians, unexplained by the multivariable model, could be related to residual confounding due to inadequate precision in the measurement of CKD risk factors or unmeasured confounding due to variables not included in the present analysis.
The strengths of the current study are the populationbased multi-ethnic sample, large sample size, objective measurement of outcome and a wealth of information on potential risk factors. The limitations of the study include its cross-sectional nature and assessment of micro/macroalbuminuria based on a single spot urinary ACR measurement resulting in nondifferential misclassification of the micro/ macroalbuminuria status and the relatively small number of subjects with severe CKD, especially stages 4 and 5.
In conclusion, the results of this population-based study showed that the prevalence of CKD is high in all three ethnic groups, in particular among Malays and Indians, but risk factors are similar to those reported from previous studies in Western populations. The positive association of diabetes, hypertension, dyslipidaemia and overweight/ obesity with CKD suggests the need to screen high-risk populations for early detection of CKD and control of modifiable risk factors to reduce the burden of CKD.
